Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 15 | 2022 | 248 | 2.140 |
Why?
|
| Catheter Ablation | 14 | 2022 | 229 | 1.720 |
Why?
|
| Electric Countershock | 12 | 2013 | 130 | 1.090 |
Why?
|
| Defibrillators, Implantable | 13 | 2013 | 329 | 0.830 |
Why?
|
| Cor Triatriatum | 1 | 2021 | 5 | 0.810 |
Why?
|
| Sotalol | 2 | 2022 | 5 | 0.610 |
Why?
|
| Anti-Arrhythmia Agents | 3 | 2022 | 97 | 0.590 |
Why?
|
| Tachycardia, Supraventricular | 5 | 2000 | 73 | 0.460 |
Why?
|
| Atrial Flutter | 3 | 2019 | 16 | 0.340 |
Why?
|
| Electrocardiography | 11 | 2000 | 601 | 0.320 |
Why?
|
| Heart Atria | 5 | 2013 | 206 | 0.300 |
Why?
|
| Tachycardia, Ventricular | 8 | 2000 | 153 | 0.300 |
Why?
|
| Cardiac Pacing, Artificial | 5 | 2010 | 174 | 0.240 |
Why?
|
| Pacemaker, Artificial | 6 | 2013 | 157 | 0.230 |
Why?
|
| Differential Threshold | 3 | 2010 | 27 | 0.220 |
Why?
|
| Ventricular Fibrillation | 2 | 1996 | 85 | 0.220 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2016 | 239 | 0.190 |
Why?
|
| Humans | 39 | 2022 | 68549 | 0.190 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2005 | 450 | 0.180 |
Why?
|
| Heart | 3 | 2020 | 850 | 0.170 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 2 | 2013 | 85 | 0.170 |
Why?
|
| Transposition of Great Vessels | 1 | 2000 | 51 | 0.170 |
Why?
|
| Tricuspid Valve | 1 | 2019 | 42 | 0.170 |
Why?
|
| Parasympathetic Nervous System | 1 | 1999 | 14 | 0.170 |
Why?
|
| Sympathetic Nervous System | 1 | 1999 | 81 | 0.160 |
Why?
|
| Pulmonary Veins | 1 | 2019 | 56 | 0.160 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2010 | 116 | 0.160 |
Why?
|
| Bundle of His | 2 | 1996 | 21 | 0.160 |
Why?
|
| Matrix Metalloproteinases | 2 | 2013 | 223 | 0.160 |
Why?
|
| Recurrence | 7 | 2020 | 948 | 0.150 |
Why?
|
| Bundle-Branch Block | 2 | 1995 | 50 | 0.150 |
Why?
|
| Cardiac Catheterization | 3 | 2004 | 419 | 0.140 |
Why?
|
| Tachycardia, Ectopic Atrial | 1 | 1996 | 2 | 0.140 |
Why?
|
| Electrosurgery | 1 | 1996 | 15 | 0.130 |
Why?
|
| Action Potentials | 1 | 2016 | 223 | 0.120 |
Why?
|
| Myocardial Infarction | 2 | 1990 | 807 | 0.120 |
Why?
|
| Heart Block | 3 | 1997 | 49 | 0.120 |
Why?
|
| Treatment Outcome | 9 | 2020 | 7028 | 0.120 |
Why?
|
| Postoperative Complications | 2 | 2019 | 1615 | 0.120 |
Why?
|
| beta-Alanine | 1 | 2013 | 20 | 0.110 |
Why?
|
| Antithrombins | 1 | 2013 | 32 | 0.110 |
Why?
|
| Aged | 14 | 2013 | 14842 | 0.100 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 1992 | 34 | 0.100 |
Why?
|
| Male | 23 | 2020 | 37283 | 0.100 |
Why?
|
| Heart Conduction System | 3 | 1997 | 119 | 0.100 |
Why?
|
| Benzimidazoles | 1 | 2013 | 128 | 0.100 |
Why?
|
| Adenosine | 1 | 1992 | 165 | 0.100 |
Why?
|
| Middle Aged | 17 | 2020 | 21119 | 0.100 |
Why?
|
| Prostheses and Implants | 1 | 1992 | 159 | 0.100 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 3 | 1997 | 12 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 2324 | 0.090 |
Why?
|
| Equipment Design | 4 | 1996 | 500 | 0.090 |
Why?
|
| Myocardial Reperfusion | 1 | 1989 | 32 | 0.080 |
Why?
|
| Phenethylamines | 1 | 2009 | 20 | 0.080 |
Why?
|
| Ventricular Dysfunction | 1 | 2009 | 15 | 0.080 |
Why?
|
| Female | 18 | 2020 | 38021 | 0.080 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2009 | 100 | 0.080 |
Why?
|
| Heart Septum | 1 | 2008 | 84 | 0.080 |
Why?
|
| Adult | 11 | 2008 | 21379 | 0.080 |
Why?
|
| Heart Ventricles | 2 | 2010 | 738 | 0.080 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 277 | 0.080 |
Why?
|
| Thrombosis | 1 | 2009 | 218 | 0.080 |
Why?
|
| Sulfonamides | 1 | 2009 | 141 | 0.080 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2008 | 141 | 0.070 |
Why?
|
| Anticoagulants | 2 | 2009 | 356 | 0.070 |
Why?
|
| Electrodes, Implanted | 3 | 1996 | 98 | 0.070 |
Why?
|
| Tachycardia | 2 | 1996 | 53 | 0.070 |
Why?
|
| Thromboembolism | 1 | 2005 | 91 | 0.060 |
Why?
|
| Atrial Premature Complexes | 1 | 2004 | 1 | 0.060 |
Why?
|
| Syncope | 2 | 1996 | 23 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2022 | 7268 | 0.060 |
Why?
|
| Vena Cava, Superior | 1 | 2004 | 41 | 0.060 |
Why?
|
| Dogs | 3 | 1996 | 490 | 0.060 |
Why?
|
| Follow-Up Studies | 6 | 2008 | 3256 | 0.060 |
Why?
|
| Isoproterenol | 2 | 2004 | 163 | 0.060 |
Why?
|
| Adrenergic beta-Agonists | 2 | 2004 | 92 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 1465 | 0.060 |
Why?
|
| Heart Defects, Congenital | 3 | 2000 | 596 | 0.050 |
Why?
|
| Prospective Studies | 5 | 2013 | 3703 | 0.050 |
Why?
|
| Ethanol | 1 | 2008 | 892 | 0.050 |
Why?
|
| Adolescent | 3 | 2000 | 8904 | 0.050 |
Why?
|
| Heart Rate | 2 | 2000 | 568 | 0.050 |
Why?
|
| Bradycardia | 2 | 1998 | 45 | 0.050 |
Why?
|
| Equipment Failure | 2 | 1997 | 112 | 0.050 |
Why?
|
| Time Factors | 4 | 2013 | 4655 | 0.050 |
Why?
|
| Myocardium | 1 | 2006 | 1204 | 0.040 |
Why?
|
| Parasympatholytics | 1 | 1999 | 19 | 0.040 |
Why?
|
| Atropine | 1 | 1999 | 29 | 0.040 |
Why?
|
| Phenylephrine | 1 | 1999 | 61 | 0.040 |
Why?
|
| Sympathomimetics | 1 | 1999 | 16 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 1999 | 334 | 0.040 |
Why?
|
| Atrioventricular Node | 1 | 1997 | 39 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 1999 | 648 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 219 | 0.040 |
Why?
|
| Sick Sinus Syndrome | 1 | 1996 | 18 | 0.030 |
Why?
|
| Electrophysiology | 2 | 2000 | 160 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2009 | 951 | 0.030 |
Why?
|
| Tachycardia, Sinoatrial Nodal Reentry | 1 | 1996 | 2 | 0.030 |
Why?
|
| Fluoroscopy | 1 | 1997 | 152 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 1996 | 218 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 929 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 2356 | 0.030 |
Why?
|
| Sheep | 1 | 1994 | 128 | 0.030 |
Why?
|
| Computer Simulation | 1 | 1997 | 706 | 0.030 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 1995 | 117 | 0.030 |
Why?
|
| Dabigatran | 1 | 2013 | 35 | 0.030 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2013 | 101 | 0.030 |
Why?
|
| Coronary Disease | 1 | 1994 | 358 | 0.030 |
Why?
|
| Heart Rate, Fetal | 1 | 1992 | 12 | 0.030 |
Why?
|
| Stroke | 1 | 2005 | 2162 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 180 | 0.030 |
Why?
|
| Electricity | 1 | 1992 | 33 | 0.030 |
Why?
|
| Equipment Safety | 1 | 1992 | 50 | 0.030 |
Why?
|
| Survival Rate | 2 | 2008 | 1055 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 546 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 1995 | 1140 | 0.020 |
Why?
|
| Fibrosis | 1 | 2013 | 371 | 0.020 |
Why?
|
| Physical Education and Training | 1 | 1991 | 24 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2013 | 483 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 1046 | 0.020 |
Why?
|
| Risk Factors | 2 | 2013 | 5720 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2010 | 260 | 0.020 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2009 | 61 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 1999 | 4843 | 0.020 |
Why?
|
| Logistic Models | 1 | 2013 | 1419 | 0.020 |
Why?
|
| Injections, Intralesional | 1 | 2008 | 25 | 0.020 |
Why?
|
| Child | 1 | 2000 | 6401 | 0.020 |
Why?
|
| Comorbidity | 1 | 2013 | 1425 | 0.020 |
Why?
|
| Probability | 1 | 2008 | 244 | 0.020 |
Why?
|
| Primary Prevention | 1 | 2008 | 115 | 0.020 |
Why?
|
| Biomarkers | 1 | 2013 | 1593 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2008 | 536 | 0.020 |
Why?
|
| Animals | 3 | 1996 | 20880 | 0.020 |
Why?
|
| Pregnancy | 1 | 1992 | 2334 | 0.020 |
Why?
|
| Stroke Volume | 2 | 2000 | 586 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2006 | 118 | 0.020 |
Why?
|
| Electric Impedance | 2 | 1996 | 131 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2005 | 567 | 0.010 |
Why?
|
| Heart Failure | 2 | 2006 | 1179 | 0.010 |
Why?
|
| Ventricular Remodeling | 1 | 2006 | 318 | 0.010 |
Why?
|
| Collagen | 1 | 2006 | 636 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2008 | 2004 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 772 | 0.010 |
Why?
|
| Therapeutic Irrigation | 1 | 2000 | 63 | 0.010 |
Why?
|
| Cold Temperature | 1 | 2000 | 90 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 2000 | 136 | 0.010 |
Why?
|
| Arrhythmia, Sinus | 1 | 1998 | 6 | 0.010 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 1998 | 20 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 1998 | 172 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 1994 | 87 | 0.010 |
Why?
|
| Bicycling | 1 | 1991 | 39 | 0.010 |
Why?
|
| Autonomic Nervous System | 1 | 1991 | 31 | 0.010 |
Why?
|
| Swimming | 1 | 1991 | 38 | 0.010 |
Why?
|
| Telephone | 1 | 1990 | 160 | 0.010 |
Why?
|